EYPT logo

EyePoint Pharmaceuticals (EYPT) CAPEX

annual CAPEX:

$4.05M+$569.00K(+16.34%)
December 31, 2024

Summary

  • As of today (June 17, 2025), EYPT annual capital expenditures is $4.05 million, with the most recent change of +$569.00 thousand (+16.34%) on December 31, 2024.
  • During the last 3 years, EYPT annual CAPEX has risen by +$3.90 million (+2497.44%).
  • EYPT annual CAPEX is now at all-time high.

Performance

EYPT CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEYPTcash flow metrics

quarterly CAPEX:

$276.00K-$108.00K(-28.13%)
March 31, 2025

Summary

  • As of today (June 17, 2025), EYPT quarterly capital expenditures is $276.00 thousand, with the most recent change of -$108.00 thousand (-28.13%) on March 31, 2025.
  • Over the past year, EYPT quarterly CAPEX has dropped by -$918.00 thousand (-76.88%).
  • EYPT quarterly CAPEX is now -83.95% below its all-time high of $1.72 million, reached on September 30, 2023.

Performance

EYPT quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEYPTcash flow metrics

TTM CAPEX:

$3.13M-$918.00K(-22.66%)
March 31, 2025

Summary

  • As of today (June 17, 2025), EYPT TTM capital expenditures is $3.13 million, with the most recent change of -$918.00 thousand (-22.66%) on March 31, 2025.
  • Over the past year, EYPT TTM CAPEX has dropped by -$1.06 million (-25.26%).
  • EYPT TTM CAPEX is now -33.28% below its all-time high of $4.70 million, reached on June 30, 2024.

Performance

EYPT TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEYPTcash flow metrics

EYPT CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+16.3%-76.9%-25.3%
3 y3 years+2497.4%+85.2%+927.5%
5 y5 years+1802.3%+1625.0%+6568.1%

EYPT CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+2497.4%-84.0%+85.2%-33.3%+927.5%
5 y5-yearat high+2497.4%-84.0%>+9999.0%-33.3%+6568.1%
alltimeall timeat high>+9999.0%-84.0%>+9999.0%-33.3%>+9999.0%

EYPT CAPEX History

DateAnnualQuarterlyTTM
Mar 2025
-
$276.00K(-28.1%)
$3.13M(-22.7%)
Dec 2024
$4.05M(+16.3%)
$384.00K(-75.6%)
$4.05M(-11.0%)
Sep 2024
-
$1.57M(+74.9%)
$4.55M(-3.1%)
Jun 2024
-
$900.00K(-24.6%)
$4.70M(+12.0%)
Mar 2024
-
$1.19M(+35.2%)
$4.19M(+20.4%)
Dec 2023
$3.48M(+62.0%)
$883.00K(-48.7%)
$3.48M(+9.4%)
Sep 2023
-
$1.72M(+334.3%)
$3.19M(+19.6%)
Jun 2023
-
$396.00K(-18.2%)
$2.66M(+7.2%)
Mar 2023
-
$484.00K(-17.3%)
$2.48M(+15.6%)
Dec 2022
$2.15M(+1278.2%)
$585.00K(-51.2%)
$2.15M(+37.4%)
Sep 2022
-
$1.20M(+449.5%)
$1.56M(+214.3%)
Jun 2022
-
$218.00K(+46.3%)
$498.00K(+63.3%)
Mar 2022
-
$149.00K(>+9900.0%)
$305.00K(+95.5%)
Dec 2021
$156.00K(-56.9%)
$0.00(-100.0%)
$156.00K(-55.2%)
Sep 2021
-
$131.00K(+424.0%)
$348.00K(+0.9%)
Jun 2021
-
$25.00K(-87.0%)
$345.00K(-4.7%)
Dec 2020
$362.00K(+70.0%)
$192.00K(+50.0%)
$362.00K(+105.7%)
Sep 2020
-
$128.00K(+392.3%)
$176.00K(+266.7%)
Jun 2020
-
$26.00K(+62.5%)
$48.00K(+2.1%)
Mar 2020
-
$16.00K(+166.7%)
$47.00K(-77.9%)
Dec 2019
$213.00K(+61.4%)
$6000.00(>+9900.0%)
$213.00K(+2.9%)
Sep 2019
-
$0.00(-100.0%)
$207.00K(-34.5%)
Jun 2019
-
$25.00K(-86.3%)
$316.00K(-6.0%)
Mar 2019
-
$182.00K(+67.0%)
$336.00K(+119.6%)
Dec 2018
$132.00K(+22.2%)
-
-
Sep 2018
-
$109.00K(+142.2%)
$153.00K(+41.7%)
Jun 2018
$108.00K(-26.5%)
$45.00K(-4600.0%)
$108.00K(-42.9%)
Mar 2018
-
-$1000.00(<-9900.0%)
$189.00K(-8.3%)
Dec 2017
-
$0.00(-100.0%)
$206.00K(-2.4%)
Sep 2017
-
$64.00K(-49.2%)
$211.00K(+43.5%)
Jun 2017
$147.00K(+30.1%)
$126.00K(+687.5%)
$147.00K(+119.4%)
Mar 2017
-
$16.00K(+220.0%)
$67.00K(-18.3%)
Dec 2016
-
$5000.00(-89.1%)
$82.00K(-27.4%)
Jun 2016
$113.00K
$46.00K(+48.4%)
$113.00K(-28.0%)
Mar 2016
-
$31.00K(+24.0%)
$157.00K(-7.1%)
Dec 2015
-
$25.00K(+127.3%)
$169.00K(+1.8%)
DateAnnualQuarterlyTTM
Sep 2015
-
$11.00K(-87.8%)
$166.00K(+3.1%)
Jun 2015
$161.00K(-35.1%)
$90.00K(+109.3%)
$161.00K(-34.0%)
Mar 2015
-
$43.00K(+95.5%)
$244.00K(-4.3%)
Dec 2014
-
$22.00K(+266.7%)
$255.00K(+3.7%)
Sep 2014
-
$6000.00(-96.5%)
$246.00K(-0.8%)
Jun 2014
$248.00K(+264.7%)
$173.00K(+220.4%)
$248.00K(+163.8%)
Mar 2014
-
$54.00K(+315.4%)
$94.00K(+77.4%)
Dec 2013
-
$13.00K(+62.5%)
$53.00K(-26.4%)
Sep 2013
-
$8000.00(-57.9%)
$72.00K(+5.9%)
Jun 2013
$68.00K(-83.2%)
$19.00K(+46.2%)
$68.00K(+23.6%)
Mar 2013
-
$13.00K(-59.4%)
$55.00K(-9.8%)
Dec 2012
-
$32.00K(+700.0%)
$61.00K(-67.6%)
Sep 2012
-
$4000.00(-33.3%)
$188.00K(-53.6%)
Jun 2012
$405.00K(+204.5%)
$6000.00(-68.4%)
$405.00K(-12.7%)
Mar 2012
-
$19.00K(-88.1%)
$464.00K(+2.2%)
Dec 2011
-
$159.00K(-28.1%)
$454.00K(+31.6%)
Sep 2011
-
$221.00K(+240.0%)
$345.00K(+159.4%)
Jun 2011
$133.00K(+786.7%)
$65.00K(+622.2%)
$133.00K(+95.6%)
Mar 2011
-
$9000.00(-82.0%)
$68.00K(+15.3%)
Dec 2010
-
$50.00K(+455.6%)
$59.00K(+555.6%)
Sep 2010
-
$9000.00(-57.1%)
$9000.00(-95.4%)
Jun 2010
$15.00K(-92.3%)
-
-
Jun 2009
$195.00K(-28.3%)
$21.00K(+16.7%)
$195.00K(-37.7%)
Mar 2009
-
$18.00K(-63.3%)
$313.00K(-7.7%)
Dec 2008
-
$49.00K(-54.2%)
$339.00K(+14.1%)
Sep 2008
-
$107.00K(-23.0%)
$297.00K(+9.2%)
Jun 2008
$272.00K(+231.7%)
$139.00K(+215.9%)
$272.00K(+104.5%)
Mar 2008
-
$44.00K(+528.6%)
$133.00K(+49.4%)
Dec 2007
-
$7000.00(-91.5%)
$89.00K(+8.5%)
Sep 2007
-
$82.00K
$82.00K
Jun 2007
$82.00K(-92.9%)
-
-
Jun 2006
$1.15M(-55.4%)
-
-
Jun 2005
$2.59M(+607.0%)
-
-
Jun 2004
$366.30K(+928.9%)
-
-
Jun 2003
$35.60K(-37.7%)
-
-
Jun 2001
$57.10K
-
-

FAQ

  • What is EyePoint Pharmaceuticals annual capital expenditures?
  • What is the all time high annual CAPEX for EyePoint Pharmaceuticals?
  • What is EyePoint Pharmaceuticals annual CAPEX year-on-year change?
  • What is EyePoint Pharmaceuticals quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for EyePoint Pharmaceuticals?
  • What is EyePoint Pharmaceuticals quarterly CAPEX year-on-year change?
  • What is EyePoint Pharmaceuticals TTM capital expenditures?
  • What is the all time high TTM CAPEX for EyePoint Pharmaceuticals?
  • What is EyePoint Pharmaceuticals TTM CAPEX year-on-year change?

What is EyePoint Pharmaceuticals annual capital expenditures?

The current annual CAPEX of EYPT is $4.05M

What is the all time high annual CAPEX for EyePoint Pharmaceuticals?

EyePoint Pharmaceuticals all-time high annual capital expenditures is $4.05M

What is EyePoint Pharmaceuticals annual CAPEX year-on-year change?

Over the past year, EYPT annual capital expenditures has changed by +$569.00K (+16.34%)

What is EyePoint Pharmaceuticals quarterly capital expenditures?

The current quarterly CAPEX of EYPT is $276.00K

What is the all time high quarterly CAPEX for EyePoint Pharmaceuticals?

EyePoint Pharmaceuticals all-time high quarterly capital expenditures is $1.72M

What is EyePoint Pharmaceuticals quarterly CAPEX year-on-year change?

Over the past year, EYPT quarterly capital expenditures has changed by -$918.00K (-76.88%)

What is EyePoint Pharmaceuticals TTM capital expenditures?

The current TTM CAPEX of EYPT is $3.13M

What is the all time high TTM CAPEX for EyePoint Pharmaceuticals?

EyePoint Pharmaceuticals all-time high TTM capital expenditures is $4.70M

What is EyePoint Pharmaceuticals TTM CAPEX year-on-year change?

Over the past year, EYPT TTM capital expenditures has changed by -$1.06M (-25.26%)
On this page